SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use?

Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature.

• Likes
• Download5
• Share